Рак молочной железы

BEGONIA trial: durvalumab plus trastuzumab deruxtecan for HER2-low metastatic breast cancer - Bioengineer.org

BEGONIA trial: durvalumab plus trastuzumab deruxtecan for HER2-low metastatic breast cancer Bioengineer.org

2026 RISE UP Conference Targets Breast Cancer and Women’s Health Advances - Bioengineer.org

2026 RISE UP Conference Targets Breast Cancer and Women’s Health Advances Bioengineer.org

2026 RISE UP Conference Targets Breast Cancer and Women’s Health Advances - Bioengineer.org

2026 RISE UP Conference Targets Breast Cancer and Women’s Health Advances Bioengineer.org

Breast cancer survivors face fertility challenges, review finds - Bioengineer.org

Breast cancer survivors face fertility challenges, review finds Bioengineer.org

Breast cancer survivors could avoid lifelong heart medication, research suggests

Many breast cancer survivors whose treatment caused them to develop problems with their heart function can safely stop their medication after their heart recovers, and most won't need to continue treatment long term, according to a study presented at the European Society of Cardiology Congress in Munich.

Breast cancer survivors could avoid lifelong heart medication, research suggests - Medical Xpress

Breast cancer survivors could avoid lifelong heart medication, research suggests Medical Xpress

Мобильный маммограф выявил десятки случаев рака и предраковых состояний в Абатском округе - Правда.Ру

Мобильный маммограф выявил десятки случаев рака и предраковых состояний в Абатском округе Правда.Ру

Мобильный маммограф выявил десятки случаев рака и предраковых состояний в Абатском округе - Правда.Ру

Мобильный маммограф выявил десятки случаев рака и предраковых состояний в Абатском округе Правда.Ру

<![CDATA[Evolving Post–CDK4/6 Inhibitor Landscape in Advanced Breast Cancer]]>

<![CDATA[sNDA for Gedatolisib Submitted to FDA in PIK3CA-Mutant Breast Cancer]]>

Cancer biosimilars associated with lower costs for insurers and patients

Biologic drugs play an important role in treating cancers such as breast cancer and lymphoma, but their high costs can add to the financial burden of cancer care. Now, lower-cost versions known as biosimilars are gaining ground, and a new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center…

Report reveals Native Hawaiian women in U.S. have highest breast cancer incidence

Cancer data for Asian American and Native Hawaiian and Pacific Islander (NHPI) people are usually combined, hiding vast differences in cancer risk. New disaggregated data analyzed by researchers at the American Cancer Society (ACS) show that Native Hawaiian women have 27% higher breast cancer incidence than White…

ACS Report Reveals Native Hawaiian Women in U.S. Have Highest Breast Cancer Incidence; Wide Variation in Cancer Risk Among Asian American, Native Hawaiian and Pacific Islander Population

American Cancer Society researchers stress disaggregated data critical to effectively target cancer prevention and control interventions

Standard breast cancer classification may overlook important differences

Breast cancer is often classified as either estrogen receptor-positive (hormone-sensitive) or not. However, a new study from Karolinska Institutet suggests that this simplified classification may overlook important biological differences between patients that could affect treatment decisions. The results are published…

Himanshu Varshney: From Breast Cancer Research to ASCO Breakthrough 2026 Recognition - Oncodaily

Himanshu Varshney: From Breast Cancer Research to ASCO Breakthrough 2026 Recognition Oncodaily